公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 GRIFOLS BRASIL LTDA取消

44 记录

产品持有公司班级有效性
Anti-A1 Lectin80134860248GRIFOLS BRASIL LTDAIII10/07/2027
Anti-A1 Lectin Dual80134860331GRIFOLS BRASIL LTDAIII16/11/2036
Anti-C3d80134860302GRIFOLS BRASIL LTDAIII11/12/2033
Anti-Cw Mono-Type Dual80134860268GRIFOLS BRASIL LTDAIII25/11/2029
Anti-Dia Dual80134860234GRIFOLS BRASIL LTDAIII19/06/2027
Anti-H Mono-Type80134860324GRIFOLS BRASIL LTDAIII08/09/2036
Anti-H for DG Gel80134860323GRIFOLS BRASIL LTDAIII10/08/2036
Anti-Human Globulin Mono-Type (green)80134860296GRIFOLS BRASIL LTDAIII02/10/2033
Anti-IgG80134860303GRIFOLS BRASIL LTDAIII11/12/2033
Anti-Lua for DG Gel80134860271GRIFOLS BRASIL LTDAIII02/12/2029
Anti-Lub Mono-Type Dual80134860270GRIFOLS BRASIL LTDAIII25/11/2029
Anti-M Mono-Type Dual e Anti-N (LN3/MN879) Mono-Type80134860264GRIFOLS BRASIL LTDAIII02/09/2029
Anti-P1 Mono-Type Dual80134860262GRIFOLS BRASIL LTDAIII03/06/2029
Anti-S Mono-Type e Anti-s Mono-Type80134860265GRIFOLS BRASIL LTDAIII02/09/2029
Coombs Control80134860301GRIFOLS BRASIL LTDAIII04/12/2033
DG GEL COOMBS80134860092GRIFOLS BRASIL LTDAIII30/01/2036
DG GEL NEUTRAL/COOMBS80134860097GRIFOLS BRASIL LTDAIII06/02/2036
DG Gel Anti-IgG80134860155GRIFOLS BRASIL LTDAIII28/03/2036
DG Gel DC Scan Plus80134860304GRIFOLS BRASIL LTDAIII11/12/2033
Data-Cyte Extend 0.8%80134860284GRIFOLS BRASIL LTDAIII08/08/2032
Data-Cyte Plus 3%80134860300GRIFOLS BRASIL LTDAIII23/10/2033
Data-Cyte Plus P 0.8%80134860279GRIFOLS BRASIL LTDAIII30/08/2031
Data-Cyte® Plus 0.8%80134860250GRIFOLS BRASIL LTDAIII17/07/2027
Diego(a)-Cyte 0.8%80134860280GRIFOLS BRASIL LTDAIII06/09/2031
Diego(a)-Cyte 3%80134860316GRIFOLS BRASIL LTDAIII30/06/2035

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家